glyoxal has been researched along with Diabetic Glomerulosclerosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Alouffi, S; Khan, MWA | 1 |
Gao, WY; Li, H; Liu, ZF; Ma, SB; Wang, XJ | 1 |
Ahmad, K; Ahmad, S; Akhter, F; Khan, MS; Saeed, M; Shahab, U; Srivastava, AK; Tabrez, S | 1 |
Chetyrkin, SV; Chuang, P; Ham, AJ; Hudson, BG; Mathieson, PW; Pedchenko, VK; Saleem, MA; Voziyan, PA | 1 |
El Said, H; Gadag, V; Gill, VD; Han, Y; Mostafa, AA; Randell, EW; Raouf, AA; Vasdev, SC | 1 |
Bierhaus, A; Häring, HU; Lehmann, R; Nawroth, PP; Schleicher, ED | 1 |
2 review(s) available for glyoxal and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Chemistry and pathobiology of advanced glycation end products.
Topics: Aging; Deoxyglucose; Diabetes Mellitus; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Glyoxal; Humans; Kidney Glomerulus; Lipid Peroxidation; NF-kappa B; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species | 2001 |
4 other study(ies) available for glyoxal and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy.
Topics: Aged; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diacetyl; Female; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde | 2019 |
Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe³⁺: its potential role in prompt recognition of diabetes mellitus auto-antibodies.
Topics: Animals; Antigen-Antibody Complex; Arginine; Circular Dichroism; Comet Assay; Diabetes Mellitus; Diabetic Nephropathies; DNA; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Glyoxal; Humans; Leukocytes, Mononuclear; Microscopy, Fluorescence; Rabbits; Spectrophotometry, Ultraviolet | 2014 |
Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy.
Topics: Aldehydes; Arginine; Binding Sites; Cell Adhesion; Cell Physiological Phenomena; Collagen Type IV; Diabetic Nephropathies; Endothelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Glucose; Glyoxal; Humans; Integrin alphaVbeta3; Integrins; Kidney; Kidney Glomerulus; Pyridoxamine; Pyruvaldehyde; Umbilical Veins | 2005 |
Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes.
Topics: Adolescent; Adult; Aldehydes; Blood Proteins; Carbocysteine; Creatinine; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Glyoxal; Humans; Male; Serum Albumin; Sulfhydryl Compounds | 2007 |